Member Info for Yorkshirepragma

Diagnostics…share of global $40bn market
Theraputics…share of Dox / other $Xbn
Partner products…share of $ X+1bn
Telling comment in dialogue about third being possibly ‘first to clinic’.
GLA

https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html?gclid=EAIaIQobChMIqMSGlJyA9wIVybTtCh2-CwR5EAAYAiAAEgIbSPD_BwE
$40bn rising to $70bn (2027)…echoing AS comments of widening acceptance etc etc.
Together with other projects…
No brainer.
Noted AS very upbeat on alliance work.
Watch this space earlier rather than later..?
GLA

Considering the efficacy of Affimers vis antibodies, a sig. article.?
GLA

https://www.astrazeneca.com/our-therapy-areas/oncology/antibody-drug-conjugates.html

Compare and contrast…200 words..
GLA

Forgot..0 revenue…$5.6bn market cap. USA effect certainly..
Recent USA director appt Avacta assists …
Gla
https://finance.yahoo.com/quote/LEGN/

https://investors.legendbiotech.com/static-files/5c1f2394-0676-49c3-8530-38436caf485b

Clearly better presented, and invested in…but stages of development/ jvs/ licences etc etc…
It’s how you tell ‘em..
Potential however …
Gla

And successful drug conjugates are in train,with hi pot earnings etc…see below

https://www.fiercepharma.com/pharma/astrazeneca-daiichi-target-broad-breast-cancer-use-enhertu-s-win-her2-low-disease

Moderna buyout Q4?

https://www.fiercepharma.com/pharma/m-a-large-biotech-pharma-companies-will-have-1-7t-firepower-for-dealmaking-2022

1.7trillion….
How d dudy time…
Gla

Bedtime reading….protein /mRNA etc

https://www.annualreviews.org/doi/full/10.1146/annurev-bioeng-070620-033348

With a 6+ year gestation time to date, my moneys on Moderna to bring forward news.
GLA

IMHE pharma industry network is much tighter/closer together than many . All watching I’m sure ...
GLA

EAMS early access to treatment declared for treatment intolerance…

https://www.ddw-online.com/leukaemia-patients-granted-early-access-to-investigational-treatment-15646-202202/

https://www.nature.com/articles/d43747-022-00033-5

Just takes one!
GLA

https://xtalks.com/big-pharma-continues-push-into-oncology-space-with-cancer-biotech-acquisitions-2636/
Value of Avacta at this point? …£500m … after successful trails 1/2/3+Bn?
GLA

BC & Do, refShare prospects…. Price attained a high based upon KFT pot. sales which would have generated profits in £ tens of millions ann.
Just cf that with potential of share of markets ca 1bns.
You’ve right approach I hope…“Faint heart never won fair lady”…can you say that these days? ..apologies if you cannot to anyone who might take offence…

GLA

https://endpts.com/improving-cancer-drug-research-fda-reworks-and-finalizes-guidance-documents/

https://www.ft.com/content/9e4e79f7-5794-4bf6-8bda-84d0b22ad474?shareType=nongift

https://ir.mirati.com/stock-info/default.aspx#stock-chart
A tipped takeover target, spot the similarities. Ok there are differences .
GLA

For an even bigger joke…

https://www.jupiteram.com/?kurtosys_download=11195